Vanguard Group Inc's 13G/A Filing for Myriad Genetics Inc

The Vanguard Group Inc filed a Schedule 13G/A amendment with the SEC, disclosing its ownership of 7,882,515 shares of Myriad Genetics Inc's common stock, representing 8.47% of the total shares outstanding. The filing indicates that Vanguard Group Inc has sole dispositive power over 7,069,696 shares and shared dispositive power over 812,819 shares. The shares are held on behalf of Vanguard's clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts. The filing certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of influencing the control of the issuer.